4J03
Crystal structure of human soluble epoxide hydrolase complexed with fulvestrant
4J03 の概要
| エントリーDOI | 10.2210/pdb4j03/pdb |
| 分子名称 | Bifunctional epoxide hydrolase 2, PHOSPHATE ION, MAGNESIUM ION, ... (5 entities in total) |
| 機能のキーワード | domain-swapped dimer, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor |
| 由来する生物種 | Homo sapiens (human) |
| 細胞内の位置 | Cytoplasm: P34913 |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 63411.66 |
| 構造登録者 | Morisseau, C.,Pakhomova, S.,Hwang, S.H.,Newcomer, M.E.,Hammock, B.D. (登録日: 2013-01-30, 公開日: 2013-06-05, 最終更新日: 2023-09-20) |
| 主引用文献 | Morisseau, C.,Pakhomova, S.,Hwang, S.H.,Newcomer, M.E.,Hammock, B.D. Inhibition of soluble epoxide hydrolase by fulvestrant and sulfoxides. Bioorg.Med.Chem.Lett., 23:3818-3821, 2013 Cited by PubMed Abstract: The soluble epoxide hydrolase (sEH) is a key enzyme in the metabolism of epoxy-fatty acids, signaling molecules involved in numerous biologies. Toward finding novel inhibitors of sEH, a library of known drugs was tested for inhibition of sEH. We found that fulvestrant, an anticancer agent, is a potent (KI=26 nM) competitive inhibitor of sEH. From this observation, we found that alkyl-sulfoxides represent a new kind of pharmacophore for the inhibition of sEH. PubMed: 23684894DOI: 10.1016/j.bmcl.2013.04.083 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.92 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






